Ivantis Hits 2 Major Milestones for its Minimally Invasive Glaucoma Surgery (MIGS)

08 January 2018

In October, Ivantis completed its pre-market approval for Hydrus Microstent, its Minimally Invasive Glaucoma Surgery procedure. Dave Van Meter, president and CEO of Ivantis, elaborates further on the importance of this milestone: “The submission of Ivantis’ PMA marks a significant milestone toward our goal of bringing the Hydrus Microstent to market in the United States […]

Continue Reading

Vertex Venture Holdings gets funds to go global

05 October 2015

Armed with a war chest of US$600 million (S$857 million), Singapore’s largest and oldest venture capital firm is going global. The infusion of cash will allow Vertex Venture Holdings to invest in start-ups in the hot seats of innovation and technological disruption – United States, Israel and China – after having been mainly focused on […]

Continue Reading